Wright Medical Group NV (NASDAQ:WMGI) SVP Jennifer S. Walker sold 42,654 shares of the firm’s stock in a transaction that occurred on Tuesday, June 26th. The shares were sold at an average price of $26.03, for a total value of $1,110,283.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Wright Medical Group stock opened at $25.96 on Friday. Wright Medical Group NV has a one year low of $19.01 and a one year high of $29.89. The company has a market cap of $2.68 billion, a P/E ratio of -118.00 and a beta of 0.78. The company has a current ratio of 1.42, a quick ratio of 0.95 and a debt-to-equity ratio of 1.46.
Wright Medical Group (NASDAQ:WMGI) last announced its quarterly earnings data on Wednesday, May 9th. The medical device company reported ($0.01) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.06. The firm had revenue of $198.54 million for the quarter, compared to the consensus estimate of $193.69 million. Wright Medical Group had a negative return on equity of 2.58% and a negative net margin of 22.11%. The firm’s revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the business posted ($0.09) earnings per share. research analysts predict that Wright Medical Group NV will post -0.16 earnings per share for the current year.
Several equities analysts have recently weighed in on WMGI shares. ValuEngine upgraded Wright Medical Group from a “sell” rating to a “hold” rating in a research report on Tuesday, May 29th. Leerink Swann raised their target price on Wright Medical Group from $27.00 to $32.00 and gave the company an “outperform” rating in a research report on Thursday, June 21st. Oppenheimer set a $25.00 target price on Wright Medical Group and gave the company a “hold” rating in a research report on Thursday, May 10th. BidaskClub upgraded Wright Medical Group from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 4th. Finally, TheStreet upgraded Wright Medical Group from a “d+” rating to a “c-” rating in a research report on Wednesday, June 13th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $29.67.
Hedge funds have recently bought and sold shares of the business. Jane Street Group LLC acquired a new stake in Wright Medical Group during the first quarter worth $235,000. A.R.T. Advisors LLC acquired a new stake in Wright Medical Group during the first quarter worth $258,000. GSA Capital Partners LLP acquired a new stake in Wright Medical Group during the first quarter worth $270,000. Landscape Capital Management L.L.C. acquired a new stake in Wright Medical Group during the fourth quarter worth $376,000. Finally, Invictus RG acquired a new stake in Wright Medical Group during the fourth quarter worth $411,000.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.